{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:44Z","timestamp":1791910424782,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009620","name":"Gansu Province Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118299","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:38:44Z","timestamp":1785307124000},"page":"118299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Cordycepin inhibits pancreatic cancer progression and enhances gemcitabine sensitivity by targeting the CDK2\/E2F2 axis to modulate TNNI2 expression"],"prefix":"10.1016","volume":"253","author":[{"given":"Ru","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wence","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bcp.2026.118299_b0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118299_b0010","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide burden of, risk factors for, and trends in Pancreatic Cancer","volume":"160","author":"Huang","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.118299_b0015","article-title":"Cordyceps spp.: a review on its immune-stimulatory and other biological potentials","volume":"11","author":"Das","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118299_b0020","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/molecules25122735","article-title":"Cordycepin for health and wellbeing: a potent bioactive metabolite of an entomopathogenic Cordyceps medicinal fungus and its nutraceutical and therapeutic potential","volume":"25","author":"Ashraf","year":"2020","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.bcp.2026.118299_b0025","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.3390\/molecules27196576","article-title":"Chinese cordyceps: bioactive components, antitumor effects and underlying mechanism-a review","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bcp.2026.118299_b0030","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s13577-024-01100-y","article-title":"Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line","volume":"37","author":"Chai","year":"2024","journal-title":"Hum. Cell"},{"issue":"7","key":"10.1016\/j.bcp.2026.118299_b0050","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1021\/acs.jcim.1c00135","article-title":"ePharmaLib: a versatile library of e-pharmacophores to address small-molecule (poly-)pharmacology","volume":"61","author":"Moumbock","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.bcp.2026.118299_bib121","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1021\/acs.jcim.8b00312","article-title":"Evaluation of AutoDock and AutoDock Vina on the CASF-2013 Benchmark","volume":"58","author":"Gaillard","year":"2018","journal-title":"J Chem Inf Model"},{"issue":"1","key":"10.1016\/j.bcp.2026.118299_bib122","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41420-021-00779-4","article-title":"SYT8 promotes pancreatic cancer progression via the TNNI2\/ERR\u03b1\/SIRT1 signaling pathway","volume":"7","author":"Fu","year":"2021","journal-title":"Cell Death Discov"},{"issue":"29","key":"10.1016\/j.bcp.2026.118299_b0055","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1038\/s41388-023-02750-2","article-title":"Diosmetin suppresses the progression of ESCC by CDK2\/Rb\/E2F2\/RRM2 pathway and synergies with cisplatin","volume":"42","author":"Chen","year":"2023","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bcp.2026.118299_b0060","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-23-0954","article-title":"INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors","volume":"14","author":"Dietrich","year":"2024","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.bcp.2026.118299_b0065","doi-asserted-by":"crossref","first-page":"C540","DOI":"10.1152\/ajpcell.00331.2022","article-title":"Barriers and opportunities for gemcitabine in pancreatic cancer therapy","volume":"324","author":"Beutel","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118299_b0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2026.118299_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1277243","article-title":"Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy","volume":"14","author":"Miao","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118299_b0080","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.bcp.2026.118299_b0085","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.3390\/molecules26195973","article-title":"Cordycepin sensitizes cholangiocarcinoma cells to be killed by natural killer-92 (NK-92) cells","volume":"26","author":"Panwong","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.118299_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121698","article-title":"Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A\/mTOR\/SREBP1 axis in cholangiocarcinoma","volume":"327","author":"Zhou","year":"2023","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bcp.2026.118299_b0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00018-023-05030-0","article-title":"Cordycepin delays postovulatory aging of oocytes through inhibition of maternal mRNAs degradation via DCP1A polyadenylation suppression","volume":"80","author":"Li","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.118299_b0100","first-page":"345","article-title":"Cordycepin inhibits pancreatic cancer cell growth in vitro and in vivo via targeting FGFR2 and blocking ERK signaling","volume":"18","author":"Li","year":"2020","journal-title":"Chin J. Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118299_b0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2026.118299_b0110","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ccell.2021.08.009","article-title":"Expanding control of the tumor cell cycle with a CDK2\/4\/6 inhibitor","volume":"39","author":"Freeman-Cook","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118299_b0115","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.18632\/oncotarget.22879","article-title":"Troponin through the looking-glass: emerging roles beyond regulation of striated muscle contraction","volume":"9","author":"Johnston","year":"2017","journal-title":"Oncotarget"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:28:07Z","timestamp":1791908887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":22,"alternative-id":["S0006295226006386"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118299","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cordycepin inhibits pancreatic cancer progression and enhances gemcitabine sensitivity by targeting the CDK2\/E2F2 axis to modulate TNNI2 expression","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118299"}}